These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36520688)

  • 1. The Cryptococcus gattii species complex: Unique pathogenic yeasts with understudied virulence mechanisms.
    Saidykhan L; Onyishi CU; May RC
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010916. PubMed ID: 36520688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.
    Kwon-Chung KJ; Fraser JA; Doering TL; Wang Z; Janbon G; Idnurm A; Bahn YS
    Cold Spring Harb Perspect Med; 2014 Jul; 4(7):a019760. PubMed ID: 24985132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrids and hybridization in the Cryptococcus neoformans and Cryptococcus gattii species complexes.
    Samarasinghe H; Xu J
    Infect Genet Evol; 2018 Dec; 66():245-255. PubMed ID: 30342094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Network of Uruguay.
    Puime CA; Bórmida V; Pan D
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37336574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
    Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
    Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
    Chan M; Lye D; Win MK; Chow A; Barkham T
    Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
    Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
    mBio; 2012; 3(3):. PubMed ID: 22570277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of
    Oliveira LSS; Pinto LM; de Medeiros MAP; Toffaletti DL; Tenor JL; Barros TF; Neves RP; Neto RGL; Milan EP; Padovan ACB; Rocha WPDS; Perfect JR; Chaves GM
    Front Cell Infect Microbiol; 2021; 11():642658. PubMed ID: 34277464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
    Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
    mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk.
    Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM
    Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcus neoformans and Cryptococcus gattii genes preferentially expressed during rat macrophage infection.
    Goulart L; Rosa e Silva LK; Chiapello L; Silveira C; Crestani J; Masih D; Vainstein MH
    Med Mycol; 2010 Nov; 48(7):932-41. PubMed ID: 20302549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
    Hansakon A; Ngamskulrungroj P; Angkasekwinai P
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
    Carvajal SK; Melendres J; Escandón P; Firacative C
    Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten challenges on Cryptococcus and cryptococcosis.
    Del Poeta M; Casadevall A
    Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genomic differences between Cryptococcus neoformans and Cryptococcus gattii by Representational Difference Analysis (RDA).
    Faganello J; Dutra V; Schrank A; Meyer W; Schrank IS; Vainstein MH
    Med Mycol; 2009; 47(6):584-91. PubMed ID: 18668420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Horse: a potential source of Cryptococcus neoformans and Cryptococcus gattii in Egypt.
    Mohammed R; Nader SM; Hamza DA; Sabry MA
    BMC Vet Res; 2022 Jan; 18(1):17. PubMed ID: 34983525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.